跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Levopres - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Levopres
Approved
STANDARD
Levopres
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b66ea389fabfb5cb
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
b66ea389fabfb5cb
Drug Approval Philippines Name
Levopres
Product Name
Levopres
Registration Number
DRP-10604-04
Brand Name
Levopres
Generic Name
Levodropropizine
Dosage Form
Syrup
Dosage Strength
30 mg/5 mL
Manufacturer
Lloyd Laboratories, Inc.
Trader
Innogen Pharmaceuticals, Inc
Distributor
Getz Pharma (Phils.), Inc.
Issuance Date
26 April 2023
Expiry Date
22 October 2026
Pharmacologic Category
Cough Suppressant
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b66ea389fabfb5cb
Type
Standard
Back to Philippines FDA Approvals